Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT01630148 |
Date of registration:
|
26/06/2012 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries
|
Scientific title:
|
Bemiparin as a Thromboprophylaxis After Benign Gynaecological Surgeries:A Randomized Clinical Trial |
Date of first enrolment:
|
July 2012 |
Target sample size:
|
774 |
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT01630148 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Iraq
| | | | | | | |
Contacts
|
Name:
|
Mahabad S. Ali, Diploma |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Hawler Ministry of Health |
|
Name:
|
Shahla K. Alalaf, M.D |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Hawler Medical University |
|
Name:
|
Namir G. Al Tawil, Professor |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Hawler Medical University |
|
Name:
|
Rojan K. Jawad, Diploma |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Hawler Medical University |
|
Name:
|
Ariana K. Jawad, C.A.B.OG |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Hawler Ministry of Health |
| |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- female undergoing Benign gynecological surgeries.
- Having moderate,high and very high risk factors for venous thromboembolism.
- No contraindications for the use of Heparin.
Exclusion Criteria:
- Having mild risk factors for thromboembolism.
- Active vaginal bleeding.
- Thrombocytopaenia.
- any patient who is already on anticoagulant.
- Sever renal or Liver diseases.
Age minimum:
15 Years
Age maximum:
90 Years
Gender:
Female
|
Health Condition(s) or Problem(s) studied
|
Pulmonary Embolism
|
Deep Vein Thrombosis (DVT)
|
Intervention(s)
|
Drug: Bemiparin
|
Primary Outcome(s)
|
Evidences of clinical thromboembolic disease after gynaecological surgeries
[Time Frame: within the first 30 days after surgery the first 30 days]
|
Secondary Outcome(s)
|
to determine the side effects of Bemiparin injection
[Time Frame: after receiving the injections and up to 30 days after surgery]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|